| 发明名称 |
COMBINATIONS OF JAK INHIBITORS AND AT LEAST ONE OF BCR-ABL, FLT-3, FAK OR RAF KINASE INHIBITORS |
| 摘要 |
The invention provides a pharmaceutical combination comprising: a) at least one agent selected from Bcr-Abl, Flt-3, FAK and RAF kinase inhibitors; and b ) at least one JAK kinase inhibitor and a method for treating or preventing a proliferative disease using such a combination. |
| 申请公布号 |
CA2586605(A1) |
申请公布日期 |
2006.06.01 |
| 申请号 |
CA20052586605 |
申请日期 |
2005.11.22 |
| 申请人 |
NOVARTIS AG |
发明人 |
COOKE, NIGEL GRAHAM;MANLEY, PAUL W. |
| 分类号 |
A61K31/277;A61K31/4025;A61K31/517;A61K31/519;A61P35/02 |
主分类号 |
A61K31/277 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
